oxazoles has been researched along with n-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Di Cicco, G; Fletcher, J; Grayson, B; Harte, M; Iacovelli, L; Neill, JC; Ngomba, RT; Rimmer, L; Wall, MJ | 1 |
1 other study(ies) available for oxazoles and n-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide
| Article | Year |
|---|---|
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.
Topics: Allosteric Regulation; Animals; Cognition; Niacinamide; Oxazoles; Phencyclidine; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Schizophrenia | 2022 |